EV/EBITDA
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- IMGN EV/EBITDA is not available.
Performance
IMGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
IMGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
IMGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | -120.99 | -127.71 | ||
| 3 y | 3-year | -2.34 | -127.71 | ||
| 5 y | 5-year | -2.34 | -127.71 | ||
| alltime | all time | 523.50 | -5403 |
ImmunoGen EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | -121.08(+2996.7%) |
| 2022 | -3.91(-58.7%) |
| 2021 | -9.47(-81.7%) |
| 2020 | -51.80(+597.2%) |
| 2019 | -7.43(+145.2%) |
| 2018 | -3.03(-62.0%) |
| 2017 | -7.98(+1208.2%) |
| 2016 | -0.61(-93.8%) |
| 2015 | -9.85(+58.9%) |
| 2014 | -6.20(-85.0%) |
| 2013 | -41.42(+313.8%) |
| 2012 | -10.01(-18.4%) |
| 2011 | -12.27(+21.6%) |
| 2010 | -10.09(-8.9%) |
| 2009 | -11.08(+126.6%) |
| 2008 | -4.89(-52.0%) |
| Date | Value |
|---|---|
| 2007 | -10.18(-3.3%) |
| 2006 | -10.53(-23.9%) |
| 2005 | -13.84(-76.7%) |
| 2004 | -59.45(+482.8%) |
| 2003 | -10.20(+98.4%) |
| 2002 | -5.14(-91.7%) |
| 2001 | -61.70(-27.4%) |
| 2000 | -84.94(-162.0%) |
| 1999 | 136.99(-1778.8%) |
| 1998 | -8.16(+202.2%) |
| 1997 | -2.70(-72.9%) |
| 1996 | -9.95(+225.2%) |
| 1995 | -3.06(-40.0%) |
| 1993 | -5.10(-7.4%) |
| 1992 | -5.51(-47.0%) |
| 1990 | -10.39 |
FAQ
- What is the all time high EV/EBITDA for ImmunoGen?
What is the all time high EV/EBITDA for ImmunoGen?
ImmunoGen all-time high EV/EBITDA is 523.50